Kibow Biotech
From EverybodyWiki Bios & Wiki
Kibow Biotech is a company based in Philadelphia that is researching and developing dietary supplements.
History[edit]
- 1997 - Founding of Kibow [1]
- 1998 - RnD begins, Advisory Board Set up
- 2001 - First NIH grant received (drug development)
- 2002 - Second NIH grant received (dietary supplement development)
- 2003 - 5 Trademarks obtained
- 2004 - 2 US patents approved
- 2005 - 1 US patent approved
- 2006 - Positive Proof of efficacy from cats and dogs with kidney failure.[2] Licensing of product Azodyl to Vetoquinol
- 2007 - 3 patents approved in Australia, China, India. Clinical trials initiated in Canada, USA, Nigeria, Argentina
- 2009 - Launched of Human Product Kibow Biotics, Clinical trial paper publish in Current Medical Research and Opinion[3]
Management[edit]
Jack Dickstein, Ph.D. - President Emeritus
Natarajan Ranganathan, Ph.D. - Interim CEO, Senior Vice President (R&D)
Jay Ram - Vice President (Business Development and Strategic Operations)
Mary Galambert - Vice President (Marketing and Communications)
Pari Ranganathan - Vice President (Clinical and Regulatory)
References[edit]
- ↑ "About Kibow Biotech". Retrieved 10 January 2011.
- ↑ Initial Trial of Probiotic Bacteria as Therapy for Uremia in Dogs, Journal of the American Society of Nephrology 15: Oct 2004 pp. 768A PUB033
- ↑ Probiotic dietary supplementation in patients with stage 3 and 4 chronic kidney disease: a 6-month pilot scale trial in Canada, *Current Medical Research and Opinion [1]
This article "Kibow Biotech" is from Wikipedia. The list of its authors can be seen in its historical. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
